AI assistant
Beijing Yunji Technology Co., Ltd. — Capital/Financing Update 2017
Feb 20, 2017
50748_rns_2017-02-20_115368ad-bb94-4560-bf48-73ef7adda1cf.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
==> picture [231 x 76] intentionally omitted <==
(Incorporated in Bermuda with limited liability) (Stock code: 1196)
DISCLOSEABLE AND CONNECTED TRANSACTION
Reference is made to the announcements of Realord Group Holdings Limited (the “ Company ”) dated 19 January and 15 February 2017 respectively and the circular of the Company dated 27 January 2017 (the “ Circular ”) in relation to the discloseable and connected transaction in respect of the New Loan Agreement, the provision of the Corporate Guarantee and the Property Pledge under the Bank Loan Agreement and the transactions contemplated thereunder. Capitalised terms used herein shall have the same meanings as defined in the Circular unless the context requires otherwise.
The Board announces that on 20 February 2017, the Connected Borrower and the Bank have entered into the Bank Loan Agreement, pursuant to which the Group has provided the Corporate Guarantee and the Property Pledge as security for the obligations and liabilities of the Connected Borrower. On the even date, the Company as borrower and Manureen Holdings as lender have entered into the New Loan Agreement. Please refer to the Circular for the principal terms of the New Loan Agreement, the Corporate Guarantee and the Property Pledge under the Bank Loan Agreement.
By order of the Board Realord Group Holdings Limited Lin Xiaohui Chairman
Hong Kong, 20 February 2017
As at the date of this announcement, the executive Directors are Dr. Lin Xiaohui, Madam Su Jiaohua and Mr. Lin Xiaodong and the independent non-executive Directors are Mr. Yu Leung Fai, Mr. Fang Jixin and Dr. Li Jue.